RHOA and hypertensive disorder: RhoA activation contributes to vascular constriction and hypertension, and CUL3Δ9-associated ubiquitin ligase activity toward RhoA is impaired, suggesting that CUL3Δ9 mutations may act dominantly by sequestering substrate adaptors and disrupting CUL3WT complexes [16].